The Science and Manufacturing of Sleeping Pills: From Ancient Remedies to Modern Pharmacology

Background

A sleeping pill, commonly known as a sleep aid, is a medication designed to help a person fall asleep or maintain sleep. Insomnia, the inability to sleep, affects millions worldwide, making sleep aids a critical component of modern medicine. In the United States, sleep aids are divided into prescription and over‑the‑counter (OTC) categories. Most prescription options contain benzodiazepines—a class of central nervous system depressants—including chlordiazepoxide (Librium) and diazepam (Valium). In the 1990s, pharmaceutical chemists introduced non‑benzodiazepine hypnotics such as zopiclone and zaleplon (Sonata), which offer improved safety profiles. OTC sleep aids rely on antihistamines, primarily diphenhydramine, doxylamine succinate, and diphenhydramine HICI. While both prescription and OTC options can cause next‑day drowsiness, FDA regulations ensure that ingredients and labeling meet strict safety standards.

History

Sleep‑inducing substances have been used since antiquity. Ancient Greeks and Egyptians employed opium poppy extracts, whose alkaloids—morphine and heroin—were later isolated. Other herbal remedies, such as mandrake bark, henbane seeds, and lettuce juice, were prescribed as early as 300 B.C. During the Middle Ages, apothecaries offered “spongia somnifera,” a sponge soaked in wine and herbs, while Renaissance England produced “drowsy syrups.” The first synthetic sleep aid appeared in the 19th century: chloral hydrate (1832) and bromides (1857) were among the earliest chemically‑derived sedatives. The barbiturate era began in 1903 with Veronal, leading to widespread use of phenobarbital, Amytal, and Pentothal. However, barbiturates posed significant risks: high addictiveness, severe side effects, and fatal interactions with alcohol. The 1970s ushered in benzodiazepines, which initially shared many drawbacks but later improvements reduced addiction potential. By the 1990s, non‑benzodiazepine hypnotics emerged, offering faster clearance and fewer residual effects.

Raw Materials

OTC sleep aids in the United States contain one of three FDA‑approved antihistamine hypnotics: diphenhydramine HICI, diphenhydramine citrate, or doxylamine succinate. These active ingredients are combined with inactive excipients—sugars, starches, magnesium stearate, microcrystalline cellulose, and dyes—to achieve desired tablet properties such as color, shape, and dissolution rate. Despite brand diversity, the underlying formulations are largely identical, resulting in a small number of distinct manufacturing formulas nationwide.

Design

Tablet design focuses on stability, manufacturability, and patient acceptability. Chemical engineers formulate a blend that meets potency, uniformity, and dissolution specifications while ensuring the tablet can be produced efficiently in a controlled environment. Design considerations include:

• Granule size and shape for consistent compression
• Tablet hardness to withstand handling yet disintegrate quickly in the body
• Stability over the shelf life, verified through accelerated aging studies

Manufacturers prototype formulations, test them in tablet‑press machines, and iterate until the final product satisfies all regulatory criteria.

The Manufacturing Process

1. Weighing and Verification – Workers measure active and inactive ingredients in pairs, following SOPs to ensure accurate dosing. Large facilities may produce tonnage per batch; small plants handle only a few pounds.
2. Blending and Moist Granulation – Ingredients are blended, wetted with a precise water amount, and granulated using rotating hammers. The resulting paste is poured onto trays and dried in ovens, forming one‑inch layers that harden into dime‑sized granules.
3. Granulation and Screening – The dried paste is further granulated or milled, passing through sieves to produce uniform particle sizes suitable for compression.
4. Tableting – Fine granules are fed into hoppers above a rotary die table. Presses compress the powder under several tons of pressure to form tablets, which are counted, packaged, and sealed.
5. Packaging and Shipping – Finished tablets are packaged in sterile, labeled containers, assigned batch numbers, and shipped to distributors.

Quality Control

Quality assurance is embedded in every step. Raw materials undergo identity, purity, and potency tests upon arrival. Throughout manufacturing, inspectors verify SOP compliance, maintain detailed records, and perform batch sampling. Key tests include:

• Chemical assays for active ingredient concentration
• Physical tests for tablet hardness, disintegration time, and moisture content
• Stability studies to confirm shelf‑life integrity

Each batch receives a unique identifier, enabling traceability if any post‑market concerns arise. FDA Good Manufacturing Practice (GMP) regulations mandate these controls, and the agency conducts plant inspections at least biennially to ensure ongoing compliance.

The Future

Current research aims to develop sleep aids with shorter elimination half‑lives and reduced next‑day drowsiness. Zaleplon, introduced in the late 1990s, exemplifies this trend: it clears from the body in roughly five hours, making it suitable for “sleep maintenance” insomnia. Should such agents prove highly effective and safe, manufacturers may seek FDA approval to shift them from prescription to OTC status—though the agency has remained cautious, adding only one new OTC hypnotic class since 1978.

Where to Learn More

Books

Alderborn, Gooran, & Christer Nystrbom, eds. Pharmaceutical Powder Compaction Technology. New York: Marcel Dekker, Inc., 1996.

Kales, Anthony, ed. The Pharmacology of Sleep. New York: Springer‑Verlag, 1995.

Periodicals

"New Hypnotic, Zaleplon, Shows Advantages for Treating Insomnia." Psychopharmacology Update (August 1998): 1.

"Over-the-Counter Sleep Aids." Consumers’ Research Magazine (April 1995): 34.

Angela Woodward